Stay updated with breaking news from Retinal Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BCVA gains of +5.5 letters at 24 months in Cohort 4 patients BCVA gains of +7.4 letters among Cohort 4 patients with extensive OpRegen bleb coverage of the GA lesion Maintenance or increases...
MALVERN, Pa., April 29, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that...
Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that 24 month results from patients enrolled in...
Recent medical breakthroughs in RGC (retinal ganglion cell) replacement therapy offer hope for those suffering from glaucoma.
/PRNewswire/ -- Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, announced today that Chief Medical Officer...